264 related articles for article (PubMed ID: 30086287)
1. Inhibition of DPP4 enhances inhibitory synaptic transmission through activating the GLP-1/GLP-1R signaling pathway in a rat model of febrile seizures.
Zhang Y; Liu Y; Xu J; Sun Q; Yu F; Cheng J; Peng B; Liu W; Xiao Z; Yin J; Han S; He X
Biochem Pharmacol; 2018 Oct; 156():78-85. PubMed ID: 30086287
[TBL] [Abstract][Full Text] [Related]
2. The role of the GLP-1/GLP-1R signaling pathway in regulating seizure susceptibility in rats.
Zhang Y; Fang J; Feng W; Sun Q; Xu J; Xia Q
Brain Res Bull; 2018 Sep; 142():47-53. PubMed ID: 29959973
[TBL] [Abstract][Full Text] [Related]
3. DPP4 regulates the inflammatory response in a rat model of febrile seizures.
Sun Q; Zhang Y; Huang J; Yu F; Xu J; Peng B; Liu W; Han S; Yin J; He X
Biomed Mater Eng; 2017; 28(s1):S139-S152. PubMed ID: 28372289
[TBL] [Abstract][Full Text] [Related]
4. Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.
Zhu E; Hu L; Wu H; Piao L; Zhao G; Inoue A; Kim W; Yu C; Xu W; Bando YK; Li X; Lei Y; Hao CN; Takeshita K; Kim WS; Okumura K; Murohara T; Kuzuya M; Cheng XW
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710180
[TBL] [Abstract][Full Text] [Related]
5. Sitagliptin improves functional recovery via GLP-1R-induced anti-apoptosis and facilitation of axonal regeneration after spinal cord injury.
Han W; Li Y; Cheng J; Zhang J; Chen D; Fang M; Xiang G; Wu Y; Zhang H; Xu K; Wang H; Xie L; Xiao J
J Cell Mol Med; 2020 Aug; 24(15):8687-8702. PubMed ID: 32573108
[TBL] [Abstract][Full Text] [Related]
6. Influence of Dipeptidyl Peptidase-IV Inhibitor Sitagliptin on Extracellular Signal-Regulated Kinases 1/2 Signaling in Rats with Diabetic Nephropathy.
Ren X; Liu G; Wang Y; Zhang W; Xue F; Li R; Yu W
Pharmacology; 2017; 100(1-2):1-13. PubMed ID: 28329747
[TBL] [Abstract][Full Text] [Related]
7. Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism.
Liu L; Liu J; Wong WT; Tian XY; Lau CW; Wang YX; Xu G; Pu Y; Zhu Z; Xu A; Lam KS; Chen ZY; Ng CF; Yao X; Huang Y
Hypertension; 2012 Sep; 60(3):833-41. PubMed ID: 22868389
[TBL] [Abstract][Full Text] [Related]
8. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
Jackson EK; Mi Z; Tofovic SP; Gillespie DG
Hypertension; 2015 Jan; 65(1):238-49. PubMed ID: 25368027
[TBL] [Abstract][Full Text] [Related]
9. GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1.
Gray SM; Hoselton AL; Krishna R; Slentz CA; D'Alessio DA
J Clin Endocrinol Metab; 2022 Aug; 107(9):2500-2510. PubMed ID: 35775723
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome analysis of the hippocampus in novel rat model of febrile seizures.
Wang Z; Fan Y; Xu J; Li L; Heng D; Han S; Yin J; Peng B; Liu W; He X
PLoS One; 2014; 9(4):e95237. PubMed ID: 24736375
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats.
Xu J; Wang J; Cheng Y; Li X; He M; Zhu J; Han H; Wei G; Kong H; Xie W; Wang H; Zuo X
Biomed Res Int; 2018; 2018():1864107. PubMed ID: 29607314
[TBL] [Abstract][Full Text] [Related]
12. Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions.
Sternkopf M; Nagy M; Baaten CCFMJ; Kuijpers MJE; Tullemans BME; Wirth J; Theelen W; Mastenbroek TG; Lehrke M; Winnerling B; Baerts L; Marx N; De Meester I; Döring Y; Cosemans JMEM; Daiber A; Steven S; Jankowski J; Heemskerk JWM; Noels H
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):e65-e77. PubMed ID: 31893947
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 response to whey protein is less diminished by dipeptidyl peptidase-4 in comparison with responses to dextrin, a lipid and casein in rats.
Shimizu Y; Hara H; Hira T
Br J Nutr; 2021 Feb; 125(4):398-407. PubMed ID: 32713353
[TBL] [Abstract][Full Text] [Related]
14. Anticonvulsant agent DPP4 inhibitor sitagliptin downregulates CXCR3/RAGE pathway on seizure models.
Liu Y; Hou B; Zhang Y; Fan Y; Peng B; Liu W; Han S; Yin J; He X
Exp Neurol; 2018 Sep; 307():90-98. PubMed ID: 29885296
[TBL] [Abstract][Full Text] [Related]
15. Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction.
Esposito G; Cappetta D; Russo R; Rivellino A; Ciuffreda LP; Roviezzo F; Piegari E; Berrino L; Rossi F; De Angelis A; Urbanek K
Br J Pharmacol; 2017 Nov; 174(22):4070-4086. PubMed ID: 27922176
[TBL] [Abstract][Full Text] [Related]
16. Sitagliptin and shock wave-supported peripheral blood derived endothelial progenitor cell therapy effectively preserves residual renal function in chronic kidney disease in rat-role of dipeptidyl peptidase 4 inhibition.
Sung PH; Chen KH; Li YC; Chiang JY; Lee MS; Yip HK
Biomed Pharmacother; 2019 Mar; 111():1088-1102. PubMed ID: 30841422
[TBL] [Abstract][Full Text] [Related]
17. Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury.
Reichetzeder C; von Websky K; Tsuprykov O; Mohagheghi Samarin A; Falke LG; Dwi Putra SE; Hasan AA; Antonenko V; Curato C; Rippmann J; Klein T; Hocher B
Br J Pharmacol; 2017 Jul; 174(14):2273-2286. PubMed ID: 28423178
[TBL] [Abstract][Full Text] [Related]
18. Dipeptidyl Peptidase IV as a Prognostic Marker and Therapeutic Target in Papillary Thyroid Carcinoma.
Lee JJ; Wang TY; Liu CL; Chien MN; Chen MJ; Hsu YC; Leung CH; Cheng SP
J Clin Endocrinol Metab; 2017 Aug; 102(8):2930-2940. PubMed ID: 28575350
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl-peptidase 4 inhibition and the vascular effects of glucagon-like peptide-1 and brain natriuretic peptide in the human forearm.
Devin JK; Pretorius M; Nian H; Yu C; Billings FT; Brown NJ
J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25158865
[TBL] [Abstract][Full Text] [Related]
20. Hindbrain DPP-IV inhibition improves glycemic control and promotes negative energy balance.
Mietlicki-Baase EG; McGrath LE; Koch-Laskowski K; Krawczyk J; Pham T; Lhamo R; Reiner DJ; Hayes MR
Physiol Behav; 2017 May; 173():9-14. PubMed ID: 28119159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
